Skip to main content
Premium Trial:

Request an Annual Quote

What's in a Name?: Dec 1, 2000

Premium

It’s true. PE is changing its name. The parent company of Celera Genomics and Applied Biosystems has been in dire need of a better handle ever since EG&G bought the right to spell-out Perkin-Elmer. In 1999, EG&G became Perkin-Elmer, and Perkin-Elmer was relegated to its own acronym. The confusion has been too much for customers to bear. (It’s still not uncommon to hear a technician refer to his “Perkin-Elmer 3700.”)

In October, stockholders approved the inspired new moniker: “Applera.”

Assuming that the naming effort has drained PE execs of whatever creative energy they had, we offer help on logos.

 

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.